ClinicalTrials.gov record
Assessment of LBR-101 In Chronic Migraine
ClinicalTrials.gov ID: NCT02021773
Public ClinicalTrials.gov record NCT02021773. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine
Study identification
- NCT ID
- NCT02021773
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Enrollment
- 264 participants
Conditions and interventions
Conditions
Interventions
- LBR-101 High Dose Drug
- LBR-101 Low Dose Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 30, 2014
- Primary completion
- Feb 27, 2015
- Completion
- Mar 30, 2015
- Last update posted
- Dec 8, 2021
2014 – 2015
United States locations
- U.S. sites
- 57
- U.S. states
- 22
- U.S. cities
- 54
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 145 | Gilbert | Arizona | 85234 | — |
| Teva Investigational Site 130 | Phoenix | Arizona | 85032 | — |
| Teva Investigational Site 117 | Scottsdale | Arizona | 85259 | — |
| Teva Investigational Site 161 | Anaheim | California | 92801 | — |
| Teva Investigational Site 116 | Fullerton | California | 92835 | — |
| Teva Investigational Site 119 | Long Beach | California | 90806 | — |
| Teva Investigational Site 146 | Oceanside | California | 92056 | — |
| Teva Investigational Site 113 | San Francisco | California | 94109 | — |
| Teva Investigational Site 108 | Stanford | California | 94305 | — |
| Teva Investigational Site 112 | Walnut Creek | California | 94598 | — |
| Teva Investigational Site 132 | Boulder | Colorado | 80304 | — |
| Teva Investigational Site 162 | Stamford | Connecticut | 06905 | — |
| Teva Investigational Site 143 | DeLand | Florida | 32720 | — |
| Teva Investigational Site 137 | Hialeah | Florida | 33012 | — |
| Teva Investigational Site 101 | Jacksonville | Florida | 32216 | — |
| Teva Investigational Site 166 | Jacksonville | Florida | 32256 | — |
| Teva Investigational Site 129 | Maitland | Florida | 32751 | — |
| Teva Investigational Site 167 | Orlando | Florida | 32801 | — |
| Teva Investigational Site 139 | Ormond Beach | Florida | 32174 | — |
| Teva Investigational Site 140 | Port Orange | Florida | 32127 | — |
| Teva Investigational Site 149 | Atlanta | Georgia | 30342 | — |
| Teva Investigational Site 164 | Decatur | Georgia | 30030 | — |
| Teva Investigational Site 134 | Douglasville | Georgia | 30134 | — |
| Teva Investigational Site 125 | Evansville | Indiana | 47714 | — |
| Teva Investigational Site 133 | Lenexa | Kansas | 66214 | — |
| Teva Investigational Site 135 | Brockton | Massachusetts | 02301 | — |
| Teva Investigational Site 124 | New Bedford | Massachusetts | 02740 | — |
| Teva Investigational Site 151 | Springfield | Massachusetts | 01104 | — |
| Teva Investigational Site 109 | Watertown | Massachusetts | 02472 | — |
| Teva Investigational Site 115 | Worcester | Massachusetts | 01605 | — |
| Teva Investigational Site 110 | Ann Arbor | Michigan | 48104 | — |
| Teva Investigational Site 114 | Kalamazoo | Michigan | 49009 | — |
| Teva Investigational Site 150 | Golden Valley | Minnesota | 55422 | — |
| Teva Investigational Site 152 | Kansas City | Missouri | 64114 | — |
| Teva Investigational Site 107 | Springfield | Missouri | 65807 | — |
| Teva Investigational Site 104 | St Louis | Missouri | 63141 | — |
| Teva Investigational Site 148 | Reno | Nevada | 89502 | — |
| Teva Investigational Site 105 | The Bronx | New York | 10461 | — |
| Teva Investigational Site 131 | Greensboro | North Carolina | 27405-6962 | — |
| Teva Investigational Site 118 | Raleigh | North Carolina | 27607 | — |
| Teva Investigational Site 168 | Winston-Salem | North Carolina | 27103 | — |
| Teva Investigational Site 122 | Canton | Ohio | 44718 | — |
| Teva Investigational Site 141 | Cincinnati | Ohio | 45227 | — |
| Teva Investigational Site 142 | Cincinnati | Ohio | 45229-3039 | — |
| Teva Investigational Site 155 | Cleveland | Ohio | 44195 | — |
| Teva Investigational Site 102 | Columbus | Ohio | 43221 | — |
| Teva Investigational Site 127 | Oklahoma City | Oklahoma | 73112 | — |
| Teva Investigational Site 111 | Philadelphia | Pennsylvania | 19107 | — |
| Teva Investigational Site 120 | Goose Creek | South Carolina | 29445 | — |
| Teva Investigational Site 153 | Bristol | Tennessee | 37620 | — |
| Teva Investigational Site 126 | Memphis | Tennessee | 38119 | — |
| Teva Investigational Site 154 | Nashville | Tennessee | 37203 | — |
| Teva Investigational Site 128 | Arlington | Texas | 76012 | — |
| Teva Investigational Site 121 | Austin | Texas | 78731 | — |
| Teva Investigational Site 136 | Austin | Texas | 78745 | — |
| Teva Investigational Site 123 | Charlottesville | Virginia | 22911 | — |
| Teva Investigational Site 144 | Roanoke | Virginia | 24018 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02021773, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 8, 2021 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02021773 live on ClinicalTrials.gov.